EMPOWER CLINICS INC - EPWCF STOCK NEWS

Empower Clinics Inc. (OTCQB:EPWCF) announced a Memorandum of Understanding with SoLVBL Solutions to enhance data security for its diagnostic testing programs. This collaboration aims to address increasing cybersecurity threats in the healthcare sector by integrating SoLVBL's advanced cybersecurity solutions with Empower's diagnostic platforms. CEO Steven McAuley emphasized that this partnership aligns with their growth strategy in healthcare diagnostics. The agreement reflects a rising demand for data protection, especially in light of recent governmental concerns about cybersecurity.

Empower Clinics officially commences the national rollout of its clinics under the Medi Collective brand, with the grand opening of its second clinic in Etobicoke, Ontario set for October 18, 2021. The company now has a pipeline of 33 clinic locations across Canada, expanding into Alberta, British Columbia, and New Brunswick. Anticipated revenues per clinic range from $2.56 million to $3.6 million annually. CEO Steven McAuley highlighted the increasing demand from healthcare partners as a driving force behind this expansion.

Empower Clinics Inc (OTCQB: EPWCF) announced its common shares will now trade on the OTCQB Venture Market effective September 10, 2021. This transition enhances the company's visibility and access to U.S. investors, including both retail and institutional. The OTCQB is recognized for supporting entrepreneurial companies, which aligns with Empower’s aggressive expansion in North America’s integrated healthcare sector. Empower will continue to be listed on the Canadian Securities Exchange under the ticker CBDT and on the Frankfurt Stock Exchange as 8EC.

Empower Clinics Inc. (EPWCF) has officially opened its inaugural medical clinic, The Medi-Collective, in Hamilton, Ontario. This strategic expansion aims to enhance patient access to integrated healthcare services, including telemedicine and diagnostics. The clinic is now accepting new patients and walk-ins, marking a significant step in Empower's growth trajectory in North America. CEO Steven McAuley highlighted this launch as a catalyst for future growth, emphasizing the company's commitment to modernizing healthcare.

Empower Clinics Inc. (OTCQB:EPWCF) has announced a temporary pause in the sale of its Kai Care At-Home Covid 19 & Influenza A/B Test Kits in Canada, pending a review by Health Canada. The review involves assessing whether the kit should be classified under a higher device class. Currently, it holds a Device Class I authorization but may require a Class IV designation. Meanwhile, the test kits remain available in the U.S. market, where they continue to be used safely. The company is collaborating with Health Canada to expedite the resolution.

Empower Clinics has announced that its Kai Medical Laboratory (KAI) is registered with the U.S. Federal CARES Act Program. This designation is expected to significantly enhance KAI's revenue potential as it offers no-cost COVID-19 testing to Texas schools. KAI has initiated a pilot project set to provide testing in over 500 schools, capitalizing on the $17.1 billion federal funding for Texas schools. The program aims to alleviate testing costs for patients, benefiting uninsured individuals through the HRSA Program, thereby expanding community access to essential health services.

Empower Clinics Inc. (OTC PINK: EPWCF) reported significant growth in its Q2 2021 financial results, achieving $861,826 in total revenues, a remarkable 1005% increase from $85,775 in Q2 2020. The enhanced cash position reached $5,191,944, up from $4,889,824 at year-end 2020. The company incurred a loss from operations of $1,373,941, largely due to increased corporate activities, although net loss decreased to $412,209 from the previous year. Notably, Empower has also made strategic moves, including the acquisition of Medi+Sure Canada and a planned sale of Sun Valley for $1 million.

Empower Clinics has appointed Annette Robinson, president of the BC Pharmacy Association, to its inaugural global advisory board. This strategic move aims to enhance the company's growth through expert guidance. Robinson, a highly respected educator and pharmacist, brings over 37 years of industry experience and valuable insights from her roles in pharmacy management and advocacy. Her involvement is expected to bolster Empower's mission to provide integrated healthcare services across Canada, aligning with the company's goals of expanding diagnostic products and telemedicine solutions.

Empower Clinics has entered a Memorandum of Understanding with Pharmasave to launch a six-month pilot program for the distribution of Kai COVID-19 Testing Solutions across Canada. This initiative aims to enhance direct consumer access to testing through Pharmasave's network of over 800 independent pharmacies. Empower will provide various testing solutions, including Rapid Antigen and Saliva RT-PCR tests. The collaboration is expected to boost Empower's clinic expansion strategy while assessing business viability during the pilot.